Sarepta Therapeutics
SRPT
#1467
Rank
ยฃ9.47 B
Marketcap
ยฃ99.17
Share price
-0.77%
Change (1 day)
33.97%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Revenue for Sarepta Therapeutics (SRPT)

Revenue in 2024 (TTM): ยฃ1.27 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ1.29 Billion. In 2023 the company made a revenue of ยฃ0.97 Billion an increase over the revenue in the year 2022 that were of ยฃ0.77 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sarepta Therapeutics from 1997 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ1.27 B30.63%
2023 ยฃ0.97 B26.54%
2022 ยฃ0.77 B48.32%
2021 ยฃ0.51 B31.23%
2020 ยฃ0.39 B36.43%
2019 ยฃ0.29 B22.46%
2018 ยฃ0.23 B107.34%
2017 ยฃ0.11 B2503.45%
2016 ยฃ4.39 M419.6%
2015 ยฃ0.84 M-86.51%
2014 ยฃ6.26 M-27.3%
2013 ยฃ8.62 M-62.68%
2012 ยฃ23.09 M-23.61%
2011 ยฃ30.23 M58.63%
2010 ยฃ19.05 M75.34%
2009 ยฃ10.86 M-25.06%
2008 ยฃ14.5 M162.31%
2007 ยฃ5.52 M9294.6%
2006 ยฃ0.05 M-97.88%
2005 ยฃ2.77 M1137.2%
2004 ยฃ0.22 M-58.64%
2003 ยฃ0.54 M3.89%
2002 ยฃ0.52 M7.16%
2001 ยฃ0.48 M-43.97%
2000 ยฃ0.86 M602.26%
1999 ยฃ0.12 M-48.55%
1998 ยฃ0.24 M31.72%
1997 ยฃ0.18 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ22.30 B 1,625.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.66 B-48.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.97 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.32 B-74.85%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.65 B 27.70%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.70 B-45.09%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.27 B-79.09%๐Ÿ‡บ๐Ÿ‡ธ USA